• SENSEX 72,529.07
    -242.65 (--0.33%)
  • BANKNIFTY 54,259.95
    -211.70 (--0.39%)
  • Cube Highways
    156.41 162.00(%)
  • NSE
    1,793.70 1,878.00(%)
  • 360 ONE
    1,019.75 906.20(%)
  • SS Retail
    775.00 888.00(%)
  • Cupid
    292.35 298.95(%)
  • R Systems Intl.
    305.25 446.55(%)
  • GE Vernova T&D
    4,225.00 5,650.00(%)
  • Lords Mark Industries
    84.89 60.00(%)
  • PB Fintech.
    1,076.35 1,076.35(%)
  • Azad Engineering
    2,997.65 2,997.65(%)
  • Hero Motors
    140.75 156.03(%)
  • HDFC Bank
    720.00 1,020.35(%)
  • Reliance Industries
    1,182.05 1,182.05(%)
  • Delhivery
    418.15 524.25(%)
  • Ather Energy
    1,404.00 542.20(%)
  • Varmora Granito
    163.45 163.45(%)
  • Bharti Airtel
    1,788.00 2,174.70(%)
  • Indian Hotels Co
    725.50 757.10(%)
  • ICICI Lombard
    1,498.00 1,423.95(%)
  • Bajaj Finance
    961.65 788.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Beryl Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3982.0
  • ISIN : INE415H01017
24.55 1 (2.63%)
  • As on 29 Sep 2026 (EOD)

  • Today’s Low

    22.60

  • Today’s High

    26.50

  • Open

    23.85

  • Perv Close

    23.92

  • 52W Low

    15.92

  • 52W High

    27.60

Key Indicators

  • P/E(TTM)

    19.96

  • Mar.Cap (₹Cr.)

    12.45

  • Div & Yield %

    0.00

  • Book Value(₹)

    19.45

  • Debt-Equity Ratio

    2.63

  • AGM Date

    29-Sep-2026

  • EPS

    1.23

  • P/E Ratio

    19.96

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    12.45

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.07

  • BV (₹)

    19.50

  • Sales( ₹ in Cr.)

    18.82

  • NP (in Cr.)

    0.42

  • NP Var(%)

    -25.0

  • Div%

    0.0

  • CPS (₹)

    3.80

  • EPS (₹)

    0.80

  • Traded Value (₹ in Lakhs)

    12.45

  • 52 Week High

    27.60

  • 52 Week Low

    15.92

  • Price BSE

    25.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    12.45

  • P/C Ratio

    6.60

  • P/E Ratio

    29.80

  • Price Vs.BV

    0.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 18.82 21.15 26.73 26.89 14.60 14.09
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 18.82 21.15 26.73 26.89 14.60 14.09
Other Income 0.49 1.41 0.40 0.27 0.16 0.64
Stock Adjustments 0.74 0.34 0.17 -0.31 0.30 0.03
Total Income 20.05 22.90 27.30 26.85 15.06 14.76
EXPENDITURE :            
Raw Materials 1.28 1.12 1.48 1.25 0.90 0.76
Power and Fuel Cost 1.30 1.25 1.54 1.27 0.85 0.86
Employee Cost 2.53 2.21 1.93 1.70 1.31 1.18
Other Manufacturing Expenses 11.61 12.75 15.02 15.78 9.04 7.90
Selling and Administration Expenses 0.90 2.88 4.64 4.50 2.16 1.92
Miscellaneous Expenses 0.00 0.02 0.00 0.07 0.21 0.06
Employee Benefit Expenses 2.53 2.21 1.93 1.70 1.31 1.18
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 17.63 20.24 24.61 24.58 14.48 12.67
Operating Profit 2.43 2.65 2.68 2.27 0.60 2.09
Interest 0.35 0.54 0.47 0.47 0.46 0.47
Gross Profit 2.08 2.11 2.21 1.80 0.14 1.62
Depreciation 1.49 1.26 1.20 0.81 1.09 1.27
Profit Before Tax 0.59 0.85 1.01 0.99 -0.95 0.35
Current Tax 0.11 0.19 0.44 0.16 0.01 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.05 0.10 -0.20 0.06 -0.30 0.11
Reported Net Profit 0.42 0.57 0.77 0.77 -0.66 0.24
Extraordinary Items 0.00 0.00 0.01 0.00 0.00 0.34
Adjusted Net Profit 0.42 0.57 0.76 0.77 -0.66 -0.10
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 4.32 3.76 3.00 2.23 2.89 2.65
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 4.75 4.32 3.77 3.00 2.23 2.89
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.83 1.11 1.51 1.50 -1.29 0.47
Earnings Per Share(Adj)-Unit Curr 0.83 1.11 1.51 1.50 -1.29 0.47
Book Value 19.41 18.61 17.52 15.84 14.32 15.57
Book Value(Adj)-Unit Curr 19.41 18.61 17.52 15.84 14.32 15.57

Shareholding Pattern

  • Promoter Group

    27.82%

  • Public Share Holding

    72.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,410,750 27.82 1,410,750 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,410,750 27.82 1,410,750 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 136,194 2.69 100,294 40
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 205,896 4.06 194,096 41
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 51,450 1.01 51,450 1
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 729,489 14.38 729,489 14
Individuals holding nominal share capital up to Rs. 1 lakh 2,494,102 49.18 1,304,302 7,168
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 43,819 0.86 43,819 41
Sub Total 3,660,950 72.18 2,423,450 7,305
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 5,071,700 100.00 3,834,200 7,309

Company Background

Beryl Drugs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Beryl Drugs Ltd
  • BSE Code : 3982.0
  • ISIN : INE415H01017

  • Incorporation Year

    1993

  • Registered Office

    29 Neer Nagar Mayank Water
    Park Road Bicholi, Indore,
    Madhya Pradesh-452016

  • Telephone

  • FAX

  • Chairman

    Sudhir Sethi

  • Managing Director

    Sanjay Sethi

  • Company Secretary

    Neha Sharma

  • Auditor

    Subhash Chand Jain Anurag & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Adroit Corp. Services Pvt Ltd
    19/20 Jaferbhoy Ind,
    1st Floor Makwana Rd,Marol Naka
    Mumbai - Mumbai - 400 059

Beryl Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Beryl Drugs 24.55 19.31 18.82 19.96 6.93
Abbott India 27,266.65 7,217.19 6,929.05 35.88 43.78
Astrazeneca Phar 6,254.35 2,304.07 2,275.58 92.18 27.86
Glaxosmi. Pharma 2,787.25 3,932.76 3,790.20 44.52 58.17
Novartis India 1,933.35 393.10 354.33 48.82 15.94
Cipla 1,383.00 20,102.60 18,979.95 36.35 13.88
Bliss GVS Pharma 710.05 773.53 729.81 65.99 12.51
Fermenta Biotec. 549.30 474.15 450.25 25.64 18.77
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Guj. Themis Bio. 404.40 168.25 165.82 108.13 18.05
Ambalal Sarabhai 39.24 19.52 3.94 72.67 6.77